NC
KDNY

Nexthera Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Nexthera Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-31,000
Closed -$1.77M – 48
2017
Q2 		$1.77M Buy
+31,000
New +$1.56M 0.77% 29

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nexthera Capital's KDNY Position: Q3 2017 in Review

Nexthera Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2017, closing a stake of 31,000 shares — an estimated $1.77M sold.

Nexthera Capital first reported a position in KDNY in Q2 2017 and held it in 1 quarter. The position peaked at $1.77M in Q2 2017. 90 funds tracked by Wall St. Rank hold KDNY as of Q3 2017.

  • Nexthera Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Nexthera Capital sold 31,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2017, an estimated $1.77M.
  • Nexthera Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Nexthera Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $1.77M in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2017.

Based on Nexthera Capital's 13F filing for Q3 2017, filed 14 Nov 2017.